Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

DeLaney TF et al. - Local control with this treatment is high in patients radiated at the time of primary presentation. Spinal cord dose constraints appear to be safe. Sacral nerves receiving 77.12-77.4 Gy RBE are at risk for late toxicity.

Today in Soft Tissue/Sarcoma...keeping you current

Angiosarcoma of the Breast: A Rare Clinicopathological Entity
American Journal of Clinical Oncology, 12/08/09

Surgical treatment of pelvic chondrosarcoma involving periacetabulum
Journal of Surgical Oncology, 12/08/09

Clinical management of uterine sarcomas
The Lancet Oncology, 12/07/09